Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs

Pharmacology Biochemistry and Behavior

Volumn 82, Issue 1, 2005, Pages 125-132

  Philippens, Ingrid H C H M ^a,b   Joosen, Marloes J A ^a   Vanwersch, Raymond A P ^a  

^a TNO   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Behavior; EEG; Organophosphate; Physostigmine; Pretreatment; Soman; Stress

Indexed keywords

NERVE GAS; PHYSOSTIGMINE; SCOPOLAMINE; SOMAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EMOTIONAL STRESS; EXPERIMENTAL MODEL; GUINEA PIG; HYPERACTIVITY; INTOXICATION; MALE; MENTAL STRESS; NEUROPHARMACOLOGY; NEUROTOXICITY; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; SOLDIER; STARTLE REFLEX; SYMPTOM;

ANIMALS; CHEMICAL WARFARE AGENTS; DRUG COMBINATIONS; ELECTROENCEPHALOGRAPHY; GUINEA PIGS; PHYSOSTIGMINE; SCOPOLAMINE; SOMAN; STARTLE REACTION; STRESS;

ANIMALIA; CAVIA;

EID: 26444582945     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.07.018     Document Type: Article

References (38)

1. E.X. Abuquerque, A. Akaike, K.P. Shaw, and D.L. Rickett The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex Fundam Appl Toxicol 4 1984 S27 S33
2. S. Almog, E. Winkler, Y. Amitai, S. Dani, M. Shefi, and M. Tirosh Acute pyridostigmine overdose: a report of nine cases Isr J Med Sci 27 1991 659 663
3. N.M. Bakry, A.H. el Rashidy, A.T. Eldefrawi, and M.E. Eldefrawi Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors J Biochem Toxicol 3 1988 235 259
4. P. Carpentier, A. Foquin, F. Dorandeu, and.G. Lallement Delta activity as an early indicator for soman-induced brain damage: a review Neurotoxicology 22 2001 299 315
5. G.H.C. Clincke, and L. Werbrouck Two-way active avoidance A. Sahgal Behavioural neuroscience: a practical approach 1993 Oxford university Press Oxford 71 79
6. L.G. Costa, B.W. Schwab, and S.D. Murphy Tolerance to anticholinesterase compounds in mammals Toxicology 25 1982 79 97
7. M. Davis, D.S. Gendelman, M.D. Tischler, and P.M. Gendelman A primary acoustic startle circuit: lesion and stimulation studies J Neurosci 2 1982 791 805
8. M. Davis, W.A. Falls, S. Campeau, and M. Kim Fear-potentiated startle: a neural and pharmacological analysis Behav Brain Res 58 1993 175 198
9. I. Dvorska, P. Brust, P. Hrbas, H.J. Ruhle, T. Barth, and A. Ermisch On the blood-brain barrier to peptides: effects of immobilization stress on regional blood supply and accumulation of labelled peptides in the rat brain Endocr Regul 26 1992 77 82
10. A. Friedman, D. Kaufer, J. Shemer, I. Hendler, H. Soreq, and I. Tur-Kaspa Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response Nat Med 2 1996 1382 1385
11. D. Gall The use of therapeutic mixtures in the treatment of cholinesterase inhibition Fundam Appl Toxicol 1 1981 214 216
12. H. Gazit, I. Silman, and Y. Dudai Administration of an organophosphate causes a decrease in muscarinic receptor levels in rat brain Brain Res 174 1979 351 356
13. A.M. Gonzalez, and A. Pazos Modification of muscarinic acetylcholine receptors in the rat brain following chronic immobilization stress: an autoradiographic study Eur J Pharmacol 223 1992 25 31
14. J.J. Gordon, and L. Leadbeater The prophylactic use of l-methyl, 2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoning Toxicol Appl Pharmacol 40 1977 109 114
15. L. Harris, and D. Stitcher Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine Naunyn Schmiedebergs Arch Pharmacol 327 1984 64 69
16. J.R. Keeler, C.G. Hurst, and M.A. Dunn Pyridostigmine used as a nerve agent pretreatment under wartime conditions JAMA 266 1991 693 695
17. R. Kramis, C.H. Vanderwolf, and B.H. Bland Two types of hippocampal rhythmical slow activity in both the rabbit and the rat: relations to behavior and effects of atropine, diethyl ether, urethane, and pentobarbital Exp Neurol 49 1975 58 85
18. P.J. Lang, M.M. Bradley, and B.N. Cuthbert Emotion, attention, and the startle reflex Psychol Rev 97 1990 377 395
19. L. Leadbeater, R.H. Inns, and J.M. Rylands Treatment of poisoning by soman Fundam Appl Toxicol 5 1985 S225 S231
20. G.P. Mark, P.V. Rada, and T.J. Shors Inescapable stress enhances extracellular acetylcholine in the rat hippocampus and prefrontal cortex but not the nucleus accumbens or amygdala Neuroscience 74 1996 767 774
21. J.H. McDonough Jr., T.R. Clark, T.W. Slone Jr., D. Zoeffel, K. Brown, and S. Kim Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman Neurotoxicology 19 1998 381 391
22. I.H. Philippens, B.P. Melchers, and O.L. Wolthuis Active avoidance behavior in guinea pigs: effects of physostigmine and scopolamine Pharmacol Biochem Behav 42 1992 285 289
23. I.H. Philippens, O.L. Wolthuis, R.W. Busker, J.P. Langenberg, and B.P. Melchers Side effects of physostigmine as a pretreatment in guinea pigs Pharmacol Biochem Behav 55 1996 99 105
24. I.H. Philippens, B. Olivier, and B.P. Melchers Effects of physostigmine on the startle in guinea pigs: two mechanisms involved Pharmacol Biochem Behav 58 1997 909 913
25. I.H. Philippens, R.W. Busker, O.L. Wolthuis, B. Olivier, P.L. Bruijnzeel, and B.P. Melchers Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects Pharmacol Biochem Behav 59 1998 1061 1067
26. I.H. Philippens, B.P. Melchers, B. Olivier, and P.L. Bruijnzeel Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs Pharmacol Biochem Behav 65 2000 175 182
27. P. Riekkinen, G. Buzsaki, P. Riekkinen Jr., H. Soininen, and J. Partanen The cholinergic system and EEG slow waves Electroencephalogr Clin Neurophysiol 78 1991 89 96
28. H.S. Sharma, and P.K. Dey Impairment of blood-brain barrier (BBB) in rat by immobilization stress: role of serotonin (5-HT) Indian J Physiol Pharmacol 25 1981 111 122
29. S.M. Sherby, A.T. Eldefrawi, E.X. Albuquerque, and M.E. Eldefrawi Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor Mol Pharmacol 27 1985 343 348
30. I. Skultetyova, D. Tokarev, and D. Jezova Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats Brain Res Bull 45 1998 175 178
31. R.P. Solana, C. Gennings, W.H. Carter Jr., D. Anderson, W.J. Lennox, and R.A. Carchman Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure Fundam Appl Toxicol 15 1990 814 819
32. M. Stewart, and S.E. Fox Detection of an atropine-resistant component of the hippocampal theta rhythm in urethane-anesthetized rats Brain Res 500 1989 55 60
33. M. Stewart, and S.E. Fox Two populations of rhythmically bursting neurons in rat medial septum are revealed by atropine J Neurophysiol 61 1989 982 993
34. H.J. Tanger, R.A. Vanwersch, and O.L. Wolthuis Automated TV-based system for open field studies: effects of methamphetamine Pharmacol Biochem Behav 9 1978 555 557
35. O.A. Timofeeva, and C.J. Gordon Changes in EEG power spectra and behavioral states in rats exposed to the acetylcholinesterase inhibitor chlorpyrifos and muscarinic agonist oxotremorine Brain Res 893 2001 165 177
36. C.J. van Dongen, and O.L. Wolthuis On the development of behavioral tolerance to organophosphates. I: behavioral and biochemical aspects Pharmacol Biochem Behav 34 1989 473 481
37. C.H. Vanderwolf, and G.B. Baker Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior Brain Res 374 1986 342 356
38. O.L. Wolthuis, I.H. Philippens, and R.A. Vanwersch On the development of behavioral tolerance to organophosphates. IV: EEG and visual evoked responses Pharmacol Biochem Behav 39 1991 851 858